SELLAS Life Sciences Group, Inc.
(NASDAQ: SLS)

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

1.740

+0.200 (+12.99%)
Range 1.518 - 1.840   (21.21%)
Open 1.530
Previous Close 1.540
Bid Price 1.520
Bid Volume 10
Ask Price 1.750
Ask Volume 8
Volume 10,136,782
Value -
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis